Skip to content

Released Apr 28, 2021, after the close

10-Q filed Apr 29, 2021, 29 days after period end · 0001653477-21-000045

Q1 2021 · 10-Q
Revenue$320.30M+11.1% vs Q1 2020−1.6% vs Q4 2020
Net Income$48.70M+7.5% vs Q1 2020+5.9% vs Q4 2020
EPS Diluted$1.20+11.1% vs Q1 2020+8.1% vs Q4 2020
Gross Profit$126,200,000+10.1%
Operating Income$105,400,000+14.3%
Operating Cash Flow$51,100,000−15.1%
Free Cash Flowderived$34,100,000−16.2%
Margins · derived
Gross margin39.4%−0.4 pt vs Q1 2020
Operating margin32.9%+0.9 pt vs Q1 2020
Net margin15.2%−0.5 pt vs Q1 2020

What the release said

The release

Same quarter

MetricQ1 2021Q1 2020Q1 2019Q1 2018
Revenue$320.30M$288.20M$276.80M$235.20M
Net Income$48.70M$45.30M$22.70M$30.80M
EPS Diluted$1.20$1.08$0.54$0.72

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR